Mazhar Adli
Title
Cited by
Cited by
Year
Integrative analysis of 111 reference human epigenomes.
Nature 518 (7539), 317-30, 2015
4062*2015
Initial genome sequencing and analysis of multiple myeloma
MA Chapman, MS Lawrence, JJ Keats, K Cibulskis, C Sougnez, ...
Nature 471 (7339), 467-472, 2011
14142011
Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains
M Ku, RP Koche, E Rheinbay, EM Mendenhall, M Endoh, TS Mikkelsen, ...
PLoS Genet 4 (10), e1000242, 2008
10112008
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
C Kuscu, S Arslan, R Singh, J Thorpe, M Adli
Nature biotechnology 32 (7), 677-683, 2014
7122014
The CRISPR tool kit for genome editing and beyond
M Adli
Nature communications 9 (1), 1-13, 2018
6912018
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression
O Abdel-Wahab, M Adli, LM LaFave, J Gao, T Hricik, AH Shih, S Pandey, ...
Cancer cell 22 (2), 180-193, 2012
5242012
Genome-wide chromatin state transitions associated with developmental and environmental cues
J Zhu, M Adli, JY Zou, G Verstappen, M Coyne, X Zhang, T Durham, ...
Cell 152 (3), 642-654, 2013
5052013
Using whole-exome sequencing to identify inherited causes of autism
WY Timothy, MH Chahrour, ME Coulter, S Jiralerspong, K Okamura-Ikeda, ...
Neuron 77 (2), 259-273, 2013
4012013
Reprogramming factor expression initiates widespread targeted chromatin remodeling
RP Koche, ZD Smith, M Adli, H Gu, M Ku, A Gnirke, BE Bernstein, ...
Cell stem cell 8 (1), 96-105, 2011
3812011
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
P Koppikar, N Bhagwat, O Kilpivaara, T Manshouri, M Adli, T Hricik, F Liu, ...
Nature 489 (7414), 155-159, 2012
2942012
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivoConditional deletion of Asxl1 results in MDS
O Abdel-Wahab, J Gao, M Adli, A Dey, T Trimarchi, YR Chung, C Kuscu, ...
The Journal of experimental medicine 210 (12), 2641-2659, 2013
2532013
CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations
C Kuscu, M Parlak, T Tufan, J Yang, K Szlachta, X Wei, R Mammadov, ...
Nature methods 14 (7), 710-712, 2017
2042017
IKK-i/IKKϵ controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation
M Adli, AS Baldwin
Journal of Biological Chemistry 281 (37), 26976-26984, 2006
1972006
Genome-wide chromatin maps derived from limited numbers of hematopoietic progenitors
M Adli, J Zhu, BE Bernstein
Nature methods 7 (8), 615-618, 2010
1832010
Whole-genome chromatin profiling from limited numbers of cells using nano-ChIP-seq
M Adli, BE Bernstein
Nature protocols 6 (10), 1656-1668, 2011
1732011
Cas9-chromatin binding information enables more accurate CRISPR off-target prediction
R Singh, C Kuscu, A Quinlan, Y Qi, M Adli
Nucleic acids research 43 (18), e118-e118, 2015
1572015
Chromatin profiling by directly sequencing small quantities of immunoprecipitated DNA
A Goren, F Ozsolak, N Shoresh, M Ku, M Adli, C Hart, M Gymrek, O Zuk, ...
Nature methods 7 (1), 47-49, 2010
1402010
Live cell imaging of low-and non-repetitive chromosome loci using CRISPR-Cas9
P Qin, M Parlak, C Kuscu, J Bandaria, M Mir, K Szlachta, R Singh, ...
Nature communications 8 (1), 1-10, 2017
1272017
IKKα and IKKβ each function to regulate NF-κB activation in the TNF-induced/canonical pathway
M Adli, E Merkhofer, P Cogswell, AS Baldwin
PloS one 5 (2), e9428, 2010
1222010
Minireview: transgenerational epigenetic inheritance: focus on endocrine disrupting compounds
EF Rissman, M Adli
Endocrinology 155 (8), 2770-2780, 2014
902014
The system can't perform the operation now. Try again later.
Articles 1–20